Vestmark Advisory Solutions’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,372
Closed -$491K 437
2023
Q2
$491K Sell
5,372
-339
-6% -$27.8K 0.02% 593
2023
Q1
$420K Buy
5,711
+530
+10% +$45.9K 0.02% 612
2022
Q4
$433K Sell
5,181
-624
-11% -$56.3K 0.02% 593
2022
Q3
$562K Sell
5,805
-83
-1% -$9.9K 0.03% 510
2022
Q2
$619K Sell
5,888
-343
-6% -$43.8K 0.04% 495
2022
Q1
$1.07M Buy
6,231
+720
+13% +$108K 0.06% 339
2021
Q4
$892K Buy
5,511
+1,588
+40% +$255K 0.05% 387
2021
Q3
$585K Sell
3,923
-773
-16% -$161K 0.04% 450
2021
Q2
$1.15M Buy
4,696
+757
+19% +$199K 0.08% 294
2021
Q1
$1.04M Buy
3,939
+917
+30% +$259K 0.09% 280
2020
Q4
$886K Buy
3,022
+276
+10% +$70.8K 0.1% 260
2020
Q3
$649K Buy
2,746
+644
+31% +$146K 0.09% 283
2020
Q2
$417K Buy
2,102
+242
+13% +$45.1K 0.06% 336
2020
Q1
$341K Buy
+1,860
New +$331K 0.07% 330
2019
Q4
Sell
-2,125
Closed -$278K 259
2019
Q3
$278K Hold
2,125
0.05% 437
2019
Q2
$258K Buy
+2,125
New +$252K 0.04% 447

Other funds holding AMED

Vestmark Advisory Solutions's AMED Position: Q3 2023 in Review

Vestmark Advisory Solutions sold out of Amedisys (AMED) in Q3 2023, closing a stake of 5,372 shares — an estimated $491K sold.

Vestmark Advisory Solutions first reported a position in AMED in Q2 2019 and held it in 16 quarters. The position peaked at $1.15M in Q2 2021. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.

  • Vestmark Advisory Solutions reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
  • Vestmark Advisory Solutions sold 5,372 Amedisys shares in Q3 2023, an estimated $491K.
  • Vestmark Advisory Solutions first reported a position in Amedisys in Q2 2019 and held it in 16 quarters.
  • Vestmark Advisory Solutions's Amedisys position peaked at $1.15M in Q2 2021.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.

Based on Vestmark Advisory Solutions's 13F filing for Q3 2023, filed 6 Nov 2023.